Nanobiotix (NBTX) Debt to Equity: 2020-2025
- Nanobiotix's Debt to Equity rose 99.97% to $1.13 in Q2 2025 from the same period last year, while for Jun 2025 it was $4.26, marking a year-over-year increase of 80.00%. This contributed to the annual value of $0.76 for FY2024, which is 40.20% up from last year.
- According to the latest figures from Q2 2025, Nanobiotix's Debt to Equity is $1.13, which was up 50.23% from $0.76 recorded in Q4 2024.
- In the past 5 years, Nanobiotix's Debt to Equity ranged from a high of $1.34 in Q2 2023 and a low of $0.41 during Q2 2021.
- Its 3-year average for Debt to Equity is $0.87, with a median of $0.76 in 2024.
- As far as peak fluctuations go, Nanobiotix's Debt to Equity skyrocketed by 138.88% in 2023, and later slumped by 57.56% in 2024.
- Quarterly analysis of 5 years shows Nanobiotix's Debt to Equity stood at $0.45 in 2021, then surged by 36.69% to $0.56 in 2022, then surged by 138.88% to $0.54 in 2023, then soared by 40.20% to $0.76 in 2024, then soared by 99.97% to $1.13 in 2025.
- Its Debt to Equity was $1.13 in Q2 2025, compared to $0.76 in Q4 2024 and $0.57 in Q2 2024.
